G150 OIL

T20/C4 Sativa

Every drop contains

THC mg 6.0
CBD 1.2 mg


The G150 hybrid strain was selected from hundreds of strains that underwent a unique genetic scan. It boasts a dense and shiny inflorescence and produces a fresh pine and lemon aroma.


Dominant Terpenes

Linalool is found in lavender, rose and basil. There is evidence that it has anti-cancer and antioxidant properties and contributes to the reduction of seizures and pain. It can help fight the effects of inflammation and oxidation, protect nerve and liver cells, and expel infections. Linalool is found to have a calming and antidepressant effect.


a-Humulene is a common chemical compound in sage, ginseng, and certain plants in the Hadassi family. It has a particular characteristic aroma – In fact, it’s what gives beer its “hoppy” flavor! Scientific research suggests that terpene and its derivatives show anti-allergic, anti-inflammatory, and anti-cancer potential.

B-Caryophyllene is found in a large number of plants such as cloves, rosemary, black pepper and lavender. Scientific literature indicates that b-Caryophyllene aids in the protection of various cells in the nervous system, increasing appetite and ability to manage pain during withdrawal from addictions, such as alcoholism. It also has the potential to treat inflammation, multiple sclerosis and Parkinson’s.



* This information herein does not constitute a binding opinion and should not be relied upon except as a general review, which is not a substitute for a professional medical opinion. CANONIC cannot guarantee and is not responsible that the effects described, or similar effects, will be felt by patients. The information should not be construed as advertisement and / or recommendation and / or encouragement for the use of cannabis, which is a prohibited use by law, other than for medical purposes. The use of medical cannabis is subject to the recommendation of a specialist doctor and in accordance with a suitable license from the Ministry of Health according to law.


*Results of a preclinical study show:

For 150 CANONIC anti-inflammatory activity and pain relief

Canonic G150 has nti-inflammatory activity and even helps in relieving pain symptoms: A news release, published in January 2022, announced positive results in the reduction of inflammatory activity and pain relief in the framework of preclinical studies conducted at Hadassah Medical Center and Miguel – Institute for Scientific Research in the Galilee.

The studies also included 150 tests. The G150 results sold in Israel under the name CANONIC of the hybrid cannabis strain show that this strain has anti-inflammatory activity and even helps in relieving pain symptoms.

Based on the results, Canonic filed a patent application in relation to G150.

We all want to think that cannabis is a potential solution to specific and difficult-to-treat medical conditions, such as pain and inflammatory diseases, for which we have no ideal treatments. Nature will provide us with what we have not been able to develop ourselves. Canonic’s medical cannabis strains demonstrate impressive capabilities in reducing pain and inflammation in preclinical conditions. Indeed, cultivating whole cannabis plants that contain certain compounds in specific amounts and in tailor-made ratios to treat the target disease, with a minimum of negative side effects, is the thing we must strive for in order to benefit humanity. This is exactly what Canonic does.

Prof. Yosi Tom
Director of the Multidisciplinary Center for Cannabinoid Research at the Hebrew University and Canonical Scientific Advisor



* These studies were performed in a laboratory model system and a live model system in fish.
** Or encouraging the use of cannabis for non-medical purposes, which is / does not commit to the effects described, which may vary among patients. This information should not be construed as a recommendation and the above CANONIC is provided as an overview only Prohibited use by law. The use of medical cannabis is on the recommendation of a specialist doctor and in accordance with an appropriate license from the Ministry of Health, and after receiving initial instruction accordingly.

Together With You

You can help us develop better products! Canonic invites you to share your experiences from the treatment with us. Combined with our extensive genetic databases, your feedback can help create strains that are better suited to patients’ needs. Join us, and together we will improve the therapeutic experience.

Additional Products


Two Aces

T20/C4 Sativa


T20/C4 Sativa

Two Stars

T20/C4 Indica

Blend Kush

T20/C4 Indica


T20/C4 Indica

Mash Kush

T20/C4 Indica


T20/C4 Indica



T20/C4 Sativa

G200 OIL

T20/C4 Indica